Earnings — page 4
OCBC Banking Operations Profit Hits Record as NII Rebounds
Net interest income rose 2% to S$2.31 billion, the highest over six quarters, as loan growth and higher yields more than offset funding costs.
NAB cash earnings fall 13.4% as credit charges rise 85.7%
Cash earnings excluding large notable items were flat at $7,090 million as a $1,547 million credit impairment charge rose 85.7% from $833 million.
Vistra Raises 2026 EBITDA Range After Record Summer
Ongoing Operations Adjusted EBITDA reached $2,378 million in the third quarter, and the company lifted 2026 guidance to $7.1 billion to $7.5 billion.
Ubiquiti Reverses Margin Dip as Revenue Hits a Record
The networking maker posted $1,026.2 million of first-quarter fiscal 2027 revenue and a 47.3% GAAP gross margin.
TechTarget Cuts 2026 Adjusted EBITDA Outlook
Third-quarter revenue was $119.2 million, 2.5% below a year earlier, as the company now sees full-year sales modestly lower and Adjusted EBITDA of $80 million to $85 million.
Treace Turns Adjusted Ebitda Positive After Expense Cuts
Adjusted EBITDA reached $0.3 million in the third quarter as Treace cut operating expenses 10% and narrowed its net loss to $12.6 million.
Tredegar Posts Loss as Extrusions Profit Collapses
Consolidated EBITDA from ongoing operations fell to $4.1 million in the third quarter as Aluminum Extrusions EBITDA dropped to $2.5 million.
Scripps Turns to Profit as Political Ads Lift Local Media
Income attributable to shareholders was $20.7 million, or 21 cents a share, after $18.8 million of restructuring costs cut 14 cents a share.
Ring Energy Swings to a Loss as Derivatives Reverse
Adjusted EBITDA rose to $57.1 million as the company spent $64.0 million on drilling and infrastructure.
Minerva's Warrant Gain Flips Third-Quarter Result to Profit
The clinical-stage biopharmaceutical company recorded $1.94 a share of GAAP net income as a $109.6 million non-cash warrant fair-value gain reversed a year-earlier loss, while the C19 Phase 3 trial of roluperidone stayed on track for 2H 2027 efficacy data.
Moderna Raises 2026 Revenue Growth Outlook After Profit Turn
Third-quarter revenue reached $1.3 billion, up 29%, and the company now expects 15% to 25% full-year growth after posting $162 million of net income.
InTest Posts Record Orders as Semiconductor Demand Rebounds
Third-quarter revenue was $35.1 million, up 33.7% from a year earlier, with net earnings of $0.15 a share after a year-ago loss.
Humana Lifts 2026 Adjusted EPS Floor After a Third-Quarter Loss
The insurer posted an adjusted loss of $0.70 a share in the third quarter and raised full-year adjusted EPS guidance to at least $9.50 from at least $9.00.
Gogo Reiterates 2026 Outlook After Galileo Shipments Rise
Third-quarter revenue was $213.2 million and the company kept full-year revenue guidance at $870 million to $895 million.
Fluor Awards Record $10.9 Billion, Lifts Backlog
Third-quarter revenue was $3.7 billion as the company booked LNG Canada Phase 2 and two Chilean copper mines and affirmed 2026 adjusted EBITDA of $500 million to $525 million.
Charter Posts $6.3 Billion Franchise Impairment After Cox Close
Pro forma revenue was $16.5 billion, down 1.5%, as the company booked a $6.3 billion franchise impairment and launched a $2 billion savings plan.
Franklin Templeton Turns to $84.1 Billion of Inflows
Preliminary net income was $380.1 million, or $0.72 a share, for the quarter ended September 30, 2026, as long-term net inflows of $20.8 billion lifted AUM to $1.8 trillion.
Anika Lifts 2026 EBITDA Floor After OEM Mix Shift
Third-quarter revenue was $30.6 million, up 10% year over year, as Commercial Channel sales reached $14.0 million.
AirSculpt Cuts 2026 Outlook After Same-Center Case Drop
Third-quarter revenue was $31.9 million and Adjusted EBITDA was $0.4 million as the company lowered full-year revenue guidance to about $144 million to $146 million.
Ares CRE Posts $10 Million Profit After Office REO Sale
GAAP net income was $10.0 million, or $0.18 a share, after a $7.1 million gain on the North Carolina office property.
Itaú Unibanco Loan Growth Slows to 2.2% in Third Quarter
Net interest income with clients rose 2.6% as the BRL 1.5 trillion loan book expanded and recurring profit reached BRL 12.6 billion.
DBS NII rises 4% as markets trading income falls
Group net interest income reached SGD 3.71 billion in the third quarter, supported by a stable 1.87% net interest margin and 3% loan and deposit growth. Weaker markets trading weighed on total income, which fell 4% from the prior quarter to SGD 5.85 billion.
Commerzbank lifts nine-month operating profit to record €4.04 billion
Operating profit reached €4,037 million in the first nine months of 2026, 17.3% above the prior-year period, as net commission income rose 8.3% to €3,250 million.
Xponential Fitness Cuts 2026 Studio Opening Guidance
Third-quarter revenue was $62.3 million as the franchisor narrowed adjusted EBITDA and lowered its net new studio outlook.
Weight Watchers Narrows 2026 Outlook After Clinical Mix Shift
Clinical Subscription Revenue reached $38.0 million, 25% of the quarter's $152.9 million in sales, as Adjusted EBITDA rose 21% to $51.7 million.
Voyager Expects VY1706 Dosing in the Next Few Months
Cash, cash equivalents and marketable securities were $132.1 million at September 30, 2026, with a runway the company restated as into the second quarter of 2028.
Wheels Up Third-Quarter Revenue Falls 11% to $164.8 Million
Third-quarter 2026 Private Jet Flight revenue was $143.9 million as premium Phenom and Challenger fleet revenue rose 120% and Adjusted Contribution Margin reached 16.4%.
TSS Lifts 2026 Adjusted EBITDA Outlook After Record Integration
Third-quarter revenue reached $50.1 million as Systems Integration hit a record $16.1 million, and the company raised its 2026 Adjusted EBITDA outlook to $21 million to $23 million.
Targa Raises 2026 Adjusted EBITDA Floor to $6.0 Billion
Third-quarter adjusted EBITDA was $1,504 million, 18% above a year earlier, as the company lifted its full-year floor and 2027 dividend outlook.
Entrada Extends Cash Runway Into Fourth Quarter of 2027
Cash, cash equivalents and marketable securities were $193.0 million as of September 30, 2026, and the company said that balance is expected to fund operations into the fourth quarter of 2027.
Tapestry Raises Fiscal 2027 Sales and Earnings Outlook
First-quarter net sales were $1.89 billion, up 11% as reported and 12% pro forma, and the company lifted full-year EPS guidance to $8.25 to $8.35.
TCPC Posts $66.8 Million Third-Quarter Operating Loss
Third-quarter net investment income of $0.16 a share missed the $0.17 dividend as a $63.7 million Continuation Vehicle loss drove a $66.8 million operating loss.
Turtle Beach Restores Year-Over-Year Growth
Third-quarter net revenue reached $84.7 million, up 5.3% from a year earlier, as the gaming accessories maker reaffirmed full-year 2026 guidance.
Starling Oncology Narrows 2026 Adjusted EBITDA Range
Third-quarter Adjusted EBITDA was $3.4 million, above the $0.50 million to $1.5 million outlook, and full-year Adjusted EBITDA guidance moved to $4 million to $6 million.
Shutterstock Revenue Decline Widens After Data Collapse
Third-quarter revenue fell 33% to $173.9 million as Data, Distribution, and Services collapsed 76% to $15.8 million.
Selective Raises 2026 Investment Income Outlook
After-tax net investment income reached $127.3 million in the third quarter, and the company lifted its full-year target to $490 million from $480 million.
Seaport Narrows Third-Quarter Loss as Revenue Falls
The entertainment and hospitality company posted a $0.65 a share loss and $32.7 million of revenue in the three months ended Sept. 30, 2026.
Rezolute Completes upLIFT Enrollment, Targets Mid-December Data
Cash, cash equivalents and investments in marketable securities were $90.0 million as of September 30, 2026.
Runway Growth Cuts Originations After SWK Close
Net investment income was $15.9 million, or $0.38 a share, as funded originations fell to $8.5 million and the portfolio shrank to $1.1 billion.
Cartesian Narrows Loss as AURORA Readout Holds 2027 Date
Net loss was $11.5 million, or $0.38 a share, in the three months ended September 30, 2026, as cash of $124.7 million is still expected to fund operations into 2028.
BRC Group Posts $243 Million Loss on Babcock & Wilcox
Third-quarter revenue was $33.0 million as $128.3 million of investment losses offset $161.3 million of operating revenue, and the company booked a $243.0 million net loss, or $6.04 a share, after $226.7 million of pre-tax Babcock & Wilcox losses.
AVITA Medical Raises 2026 Guidance After Revenue Growth Accelerates
Third-quarter revenue reached $26.1 million, up 53% from a year earlier, and the company lifted full-year guidance to $92 million to $94 million.
Quantum-Si Finishes Most of 20% Workforce Cut, Lowers 2026 Costs
Third-quarter revenue was $212,000 as the company cut 2026 adjusted operating-expense guidance to $87.0 million or less and kept Proteus on track for a second-quarter 2027 launch.
Pyxis Oncology Says Cash Will Fund Operations Into First Half of 2028
The company closed a $110.0 million October offering and said combined cash will fund operations into the first half of 2028.
Portillo's Reverses Same-Store Sales Decline, Lifts Ebitda Outlook
Same-restaurant sales rose 1.4% in the third quarter after a 1.2% drop, and the company raised full-year Adjusted EBITDA guidance to $98 million to $101 million.
Insulet Approves $1 Billion Buyback Program, Raises Full-Year Outlook
Third-quarter revenue was $842.0 million, up 19.2%, or 19.6% in constant currency, slightly above the high end of the company’s constant-currency guidance range.
Perma-Fix Third-Quarter Revenue Rebounds as Net Loss Narrows Sequentially
Third-quarter revenue was $17.9 million, up 39% from the second quarter, as treatment backlog reached $19.6 million and Services turned to operating income.
Pangaea Posts Record Adjusted EBITDA as Arctic Season Peaks
Adjusted EBITDA reached $52.4 million in the third quarter, with TCE rates at $20,414 a day and a 13% premium to benchmark indices.
Organogenesis Sets 2026 Revenue at $179.4 Million to $200.0 Million
Third-quarter net product revenue was $45.5 million, down 70% from a year earlier, as the company now expects a 65% to 68% full-year decline.
Onity Restores Profit After Second-Quarter Loss
Adjusted pre-tax income reached $30 million and annualized adjusted ROE 19% as servicing more than offset weaker originations.